Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2023）
摘要
EOI2 flow-MRD is an independent prognostic factor and should be included as risk stratification factor in childhood -r AML. Treatment approaches other than allo-SCT in CR1 are needed to improve prognosis.
更多查看译文
关键词
acute myeloid leukemia,measurable residual disease,relapse risk,berlin-frankfurt-m
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要